CBAV — Clinica Baviera SA Income Statement
0.000.00%
Last trade - 00:00
- €456.47m
- €444.13m
- €224.92m
- 97
- 63
- 87
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 124 | 123 | 173 | 198 | 225 |
Cost of Revenue | |||||
Gross Profit | 110 | 107 | 151 | 173 | 198 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 106 | 102 | 133 | 157 | 175 |
Operating Profit | 18.3 | 20.5 | 39.4 | 41.1 | 50.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.8 | 20.2 | 38.9 | 40.7 | 49.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.9 | 14.1 | 27.9 | 30.1 | 36.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 12.8 | 13.9 | 27.4 | 29.5 | 36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.8 | 13.9 | 27.4 | 29.5 | 36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.786 | 0.855 | 1.68 | 1.85 | 2.2 |
Dividends per Share |